Wei Xiong
Houston Methodist(US)Zunyi Medical University(CN)Kunming Medical University(CN)Central China Normal University(CN)Wuhan Science and Technology Bureau(CN)Lentigen Technology (United States)(US)Brown Foundation(US)Hubei Cancer Hospital(CN)The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology
Most-Cited Works
- → Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion(2021)380 cited
- → Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function(2017)323 cited
- → Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma(2020)209 cited
- → Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants(2021)184 cited
- → Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells(2018)148 cited
- → Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial(2019)134 cited